SCHEMBL13765798

SCHEMBL13765798

CNCc1cncc(C(C)(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 2/20 0.37
EPHX2 P34913 1/20 0.37
NOS1 P29475 4/20 0.36
NOS2 P35228 1/20 0.36
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 1/20 0.35
DYRK1A Q13627 1/20 0.34
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
NOS3 P29474 2/20 0.33
MAP3K5 Q99683 1/20 0.32
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16619248 0.85 CYP11B2 (0.38) PRMT6EPHX2NOS1NOS2DYRK1A
SCHEMBL5018942 0.83 CYP11B1 (0.46) PRMT6EPHX2NOS1NOS2CYP11B1
SCHEMBL10259264 0.78 MAPT (0.33) NOS1NOS2MAPTALDH1A1LMNA
SCHEMBL12680204 0.77 GABRA1 (0.42) PRMT6EPHX2MAPTKDM4ECYP3A4
SCHEMBL3511729 0.76 CYP2A6 (0.41) EPHX2MAPTALDH1A1LMNAHTT
SCHEMBL13975921 0.76 AOC3 (0.36) MAPTALDH1A1LMNAHTTCYP3A4
SCHEMBL6969862 0.76 DAO (0.33) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL7429027 0.76 NPC1 (0.33) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL15706258 0.76 ESR1 (0.34) MAPTALDH1A1LMNAHTTCYP11B1
SCHEMBL16544498 0.74 DAO (0.36) NOS1NOS2NPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090561-B2 Acetylenic heteroaryl compounds ARIAD PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-8461167-B2 Acetylenic heteroaryl compounds ARIAD PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20130018046-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. (US) 2013-01-17 US disclosed
US-20090176781-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176781-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA PRMT6 2482/4885EPHX2 761/4885NOS1 4757/4885
US-20130018046-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA PRMT6 2482/4885EPHX2 761/4885NOS1 4757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.